60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 235 / 薬物数 : 381 - (DrugBank : 83) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 160

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00358657 (ClinicalTrials.gov)	May 24, 2006	28/7/2006	Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Tr ...	HLA-Haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and Other N ...	Immunodeficiency Syndrome;Non-Cancer Diagnosis;Severe Aplastic Anemia;Donor	Procedure: Allogeneic Bone Marrow Transplantation;Drug: Cyclophosphamide;Drug: Fludarabine Phosphate; ...	Fred Hutchinson Cancer Research Center	National Cancer Institute (NCI);National Heart, Lung, and Blood Institute (NHLBI)	Active, not recruiting	N/A	55 Years	All	14	Phase 2	United States
2	NCT00343785 (ClinicalTrials.gov)	February 2006	22/6/2006	Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing ...	Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation From HLA ...	Aplastic Anemia	Drug: cyclophosphamide;Biological: anti-thymocyte globulin;Drug: cyclosporine;Procedure: allogeneic ...	Fred Hutchinson Cancer Research Center	National Heart, Lung, and Blood Institute (NHLBI)	Completed	N/A	65 Years	All	21	Phase 2	United States;Canada
3	NCT00295997 (ClinicalTrials.gov)	May 2005	23/2/2006	Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, o ...	Non-myeloablative Allogeneic Stem Cell Transplantation With Match Unrelated Donors for Treatment of ...	Chronic Myeloproliferative Disorders;Kidney Cancer;Leukemia;Lymphoma;Multiple Myeloma and Plasma Cel ...	Biological: anti-thymocyte globulin;Biological: filgrastim;Biological: graft-versus-tumor induction ...	University of California, San Francisco	National Cancer Institute (NCI)	Active, not recruiting	N/A	74 Years	Both	35	N/A	United States
4	NCT00053989 (ClinicalTrials.gov)	January 29, 2002	5/2/2003	NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders	Non-Myeloablative Allogeneic Hematopoietic Peripheral Blood Stem Cell Transplantation for Hematologi ...	Chronic Myeloproliferative Disorders;Leukemia;Lymphoma;Multiple Myeloma and Plasma Cell Neoplasm;Mye ...	Biological: anti-thymocyte globulin;Biological: graft-versus-tumor induction therapy;Biological: sar ...	Roswell Park Cancer Institute	NULL	Completed	4 Years	75 Years	All	41	Phase 2	United States
5	NCT00017654 (ClinicalTrials.gov)	April 2001	6/6/2001	Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantatio ...		Graft Versus Host Disease;Aplastic Anemia	Drug: anti-thymocyte globulin;Drug: cyclophosphamide;Drug: cyclosporine;Drug: methylprednisolone;Pro ...	Northwestern Memorial Hospital	NULL	Active, not recruiting	15 Years	55 Years	Both	3	N/A	United States
6	NCT00005852 (ClinicalTrials.gov)	June 1996	2/6/2000	Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previou ...	Allogeneic Bone Marrow Transplantation for Marrow Failure States	Chronic Myeloproliferative Disorders;Graft Versus Host Disease;Leukemia;Lymphoma;Multiple Myeloma an ...	Biological: anti-thymocyte globulin;Biological: filgrastim;Biological: muromonab -CD3;Drug: cyclophos ...	H. Lee Moffitt Cancer Center and Research Institute	National Cancer Institute (NCI)	Terminated	15 Years	55 Years	Both		Phase 2	NULL

First Previous1Next Last